- Portmann, Thomas;
- Yang, Mu;
- Mao, Rong;
- Panagiotakos, Georgia;
- Ellegood, Jacob;
- Dolen, Gul;
- Bader, Patrick;
- Grueter, Brad;
- Goold, Carleton;
- Fisher, Elaine;
- Clifford, Katherine;
- Rengarajan, Pavitra;
- Kalikhman, David;
- Loureiro, Darren;
- Saw, Nay;
- Zhengqui, Zhou;
- Miller, Michael;
- Lerch, Jason;
- Henkelman, Mark;
- Shamloo, Mehrdad;
- Malenka, Robert;
- Dolmetsch, Ricardo;
- Crawley, Jacqueline
A deletion on human chromosome 16p11.2 is associated with autism spectrum disorders. We deleted the syntenic region on mouse chromosome 7F3. MRI and high-throughput single-cell transcriptomics revealed anatomical and cellular abnormalities, particularly in cortex and striatum of juvenile mutant mice (16p11(+/-)). We found elevated numbers of striatal medium spiny neurons (MSNs) expressing the dopamine D2 receptor (Drd2(+)) and fewer dopamine-sensitive (Drd1(+)) neurons in deep layers of cortex. Electrophysiological recordings of Drd2(+) MSN revealed synaptic defects, suggesting abnormal basal ganglia circuitry function in 16p11(+/-) mice. This is further supported by behavioral experiments showing hyperactivity, circling, and deficits in movement control. Strikingly, 16p11(+/-) mice showed a complete lack of habituation reminiscent of what is observed in some autistic individuals. Our findings unveil a fundamental role of genes affected by the 16p11.2 deletion in establishing the basal ganglia circuitry and provide insights in the pathophysiology of autism.